-
-
-
-
-
-
-
Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
-
-
-
-
-
-
-
Novocure reports positive phase 2 trial results for pancreatic cancer
-
-
-
-
-
-
-
Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)
-
-
-
-
-
-
-
Novocure names Frank Leonard as CEO, replacing Ashley Cordova
-
-
-
-
-
-
-
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
-
-
-
-
-
-
-
NovoCure gains health coverage in Spain for glioblastoma therapy
-
-
-
-
-
-
-
Novocure to Report Second Quarter 2025 Financial Results
-
1,231,050 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


